24 vaccines in human clinical trial stage,150 vaccines in pre-clinical

▴ inida-frontrunner-corona-vaccine-race-worldwide
WHO Chief Scientist Dr. Soumya Swaminathan says, 24 vaccine candidates in human clinical trial stage, 150 vaccines in pre-clinical stages worldwide

Chief Scientist, World Health Organization Dr. Soumya Swaminathan has said that 24 vaccine candidates are in the human clinical trial stage and 150 vaccines are in the pre-clinical stages worldwide. She said, WHO has a robust pipeline of potential COVID vaccine candidates and the more vaccine candidates will maximize the opportunities.

Dr Swaminathan said, three vaccine candidates are in the Phase-3 trial stage which are Oxford vaccine developed by Astrazeneca, mRNA-1273 by Moderna and the chinease vaccine. She said, vaccine development is lengthy and complex process which takes time, but harmonization at different level will fasten the process. She said, the safety and efficacy of the vaccine is very important in the vaccine development process.

Meanwhile, India has become one of the frontrunners in the global effort to develop a vaccine for the containment of COVID-19. Government agencies have stepped up collaboration with private partners to Fastrack the approval process needed for the development of a potential COVID vaccine.

Human clinical trials of the indigenous COVID vaccines have been started at the various levels in the country to identify the efficacy of these potential vaccines. Bharat Biotech and Zydus Cadila have initiated human clinical trials of their vaccines after getting approval from the government.

Government has assured to provide all the necessary support for the development of vaccine saying that all the regulatory process will be ensured. ICMR and Bharat Biotech have joined hands for the development of potential COVID-19 vaccine called 'Covaxin' whereas the Department of Biotechnology has partially funded the development of Zydus's vaccine ZyCov-D. India is considered a pharmacy of the world and 60 percent of the vaccine at the world level is supplied by India.

A top Indian pharma company Serum Institute of India has bagged a contract with British drugmaker AstraZeneca to supply one billion doses of Oxford University's potential COVID-19 vaccine. This vaccine is currently at the third level of the human clinical trial stage.

Tags : #CoronaVaccine #WHO #BharatBiotech #ZydusCadila #Zycov-D #Covaxin #ICMR #AstraZeneca #SerumInstitute

About the Author

Team Medicircle

Related Stories

Loading Please wait...

Trending Now

Novavax and Takeda Announce collaboration for Novavax’ COVID-19 vaccine candidate in JapanAugust 08, 2020
First liquid biopsy from Guardant Health to receive FDA ApprovalAugust 08, 2020
Maharashtra CM directs officials to bring down COVID-19 mortality rate in stateAugust 08, 2020
Cases Increase In Italy August 08, 2020
Germany Increases COVID-19 Restrictions August 08, 2020
Saudi Arabia announces rise of 38 in new COVID-19 deathsAugust 08, 2020
Obesity and COVID-19: Blame isn't a strategyAugust 08, 2020
A COVID-19 Vaccine Could Be Ready Sooner Than You ThinkAugust 08, 2020
UK's rapid Covid test not yet approved by regulatorsAugust 08, 2020
Facebook Work From Home Until July 2021August 08, 2020
August is Vision and Learning Month!August 08, 2020
Recovery Rate at 68% while CFR at 2.05% ; India Covid News Update Aug 8August 08, 2020
Meghalaya, Nagaland, Tripura, Mizoram COVID news update ; Aug 8 2020August 08, 2020
States, UTs to conduct Coronavirus tests of all grocery shop workers and street vendors August 08, 2020
Moderna signs up COVID Vaccine deal with Swiss government August 08, 2020
BMC makes home quarantine compulsory for domestic travellersAugust 08, 2020
Gujarat: COVID recovery rate reaches 75.04%, over 9.30 lakh tests conductedAugust 08, 2020
Serum Institute puts a ceiling of Rs 225 ,would produce 100 million doses of vaccineAugust 08, 2020
Indian Pharma on growth path, only hurdle, regulatory interventions ; PWCAugust 07, 2020
Karnataka: COVID-19 recovery rate improves to 50.73 pctAugust 07, 2020